Repligen RGEN
NASDAQ RGEN
$178.16 +5.25 (+3.04%)
As of: Sep 17, 2026 · 3:59 PM EDT

Repligen (RGEN) Cash & Equivalents (QoQ) (2010 - 2026)

Analysis

Repligen (RGEN) Cash & Equivalents (QoQ) (2010 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.30%
Mar 31, 2026 2.20%
Dec 31, 2025 2.52%
Sep 30, 2025 5.63%
Jun 30, 2025 1.67%
Mar 31, 2025 -7.97%
Dec 31, 2024 -3.36%
Sep 30, 2024 -3.11%
Jun 30, 2024 3.65%
Mar 31, 2024 3.90%
Dec 31, 2023 19.11%
Sep 30, 2023 4.49%
Jun 30, 2023 16.85%
Mar 31, 2023 -1.31%
Dec 31, 2022 -8.70%
Sep 30, 2022 -3.88%
Jun 30, 2022 2.03%
Mar 31, 2022 -3.18%
Dec 31, 2021 -2.78%
Sep 30, 2021 -15.42%